| J0897 | Injection, denosumab, 1 mg | 7,080 | $20 | $127.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,040 | $110 | $111.9K |
| J3262 | Injection, tocilizumab, 1 mg | 25,120 | $1 | $100.5K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 12,180 | $10 | $97.4K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 18,000 | $1 | $72K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 4,500 | $10 | $49.5K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,350 | $30 | $35.1K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 170 | $130 | $22.1K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 210 | $70 | $14.8K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 150 | $70 | $10.9K |